---
title: CDMO Daily News — October 31, 2026
slug: daily-news-2026-10-31-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: October 31 CDMO daily: Altruist Biologics Receives NMPA Priority Review for Localized Biologic Drug Manufacturing; Codis Advances UK Operations with PSD-4…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-10-31-cdmo
published_at: 2026-10-31T00:02:31.005Z
last_updated: 2026-10-31T00:03:58.452Z
---

### [Altruist Biologics](/companies/altruist-biologics) Receives NMPA Priority Review for Localized Biologic Drug Manufacturing
- [Altruist Biologics](/companies/altruist-biologics) has secured NMPA priority review for a new drug application for localized biologic drug manufacturing.
- The Hangzhou facility has a total antibody manufacturing capacity of 172,000 liters, with 80,000 liters currently operational.

**Operational Impact**

The NMPA's acceptance of the NDA will accelerate the transition of manufacturing from overseas to Altruist's domestic facility in China.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cdmo-news/altruist-biologics-secures-nmpa-priority-review-for-localized-biologic-drug-manufacturing)*

---

### [Codis](/companies/codis) Advances UK Operations with PSD-4 Expansion Following Facility Demolition
- [Codis](/companies/codis) has completed the demolition of redundant facilities at its Haverhill, UK site, paving the way for a new PSD-4 spray dryer construction.
- The PSD-4 expansion will enhance Codis' commercial-scale solvent-based spray drying capacity, enabling clients to manufacture poorly soluble drug candidates.

**Operational Impact**

The PSD-4 expansion will significantly boost [Codis](/companies/codis)' capacity for producing amorphous solid dispersions, benefiting pharmaceutical clients in the UK.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/codis-completes-redundant-uk-facility-demolition-starts-construction-on-psd-4-expansion)*

---

### [Piramal Pharma Solutions](/companies/piramalpharmasolutions) Recognized for Innovative Patient-Centric Dashboard at Pithampur Site
- [Piramal Pharma Solutions](/companies/piramalpharmasolutions) has won the Excellence in Patient Centricity Award for its Integrated Patient Impact Dashboard at the Pithampur site.
- The dashboard tracks an average monthly supply of 39.8 million units across 24 products, reaching a potential 34.08 million lives.

**Operational Impact**

The dashboard's insights into production and patient reach at the Pithampur site support data-informed decisions that enhance patient safety and quality.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cdmo-news/piramal-pharma-solutions-wins-patient-centricity-award-for-pithampur-dashboard)*

## References

1. [PharmaSource RSS — Altruist Biologics Receives NMPA Priority Review for Localized Biologic Drug Manufacturing](https://pharmasource.global/content/news/cdmo-news/altruist-biologics-secures-nmpa-priority-review-for-localized-biologic-drug-manufacturing)
2. [Contract Pharma Breaking News RSS — Codis Advances UK Operations with PSD-4 Expansion Following Facility Demolition](https://www.contractpharma.com/breaking-news/codis-completes-redundant-uk-facility-demolition-starts-construction-on-psd-4-expansion)
3. [PharmaSource RSS — Piramal Pharma Solutions Recognized for Innovative Patient-Centric Dashboard at Pithampur Site](https://pharmasource.global/content/news/cdmo-news/piramal-pharma-solutions-wins-patient-centricity-award-for-pithampur-dashboard)

Source: https://www.cdmo.directory/posts/daily-news-2026-10-31-cdmo